brocresine has been researched along with 3,4-dihydroxyphenylacetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorenzo, AV; Snodgrass, SR; Uretsky, NJ | 1 |
| Cohen, G; Spina, MB | 1 |
| Ben Shachar, D; Stephenson, G; Youdim, MB | 1 |
3 other study(ies) available for brocresine and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Brocresine; Corpus Striatum; Dopamine; Homovanillic Acid; In Vitro Techniques; Male; Methyltyrosines; p-Hydroxyamphetamine; Rats; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 1975 |
Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brocresine; Carbidopa; Catalase; Chromatography, High Pressure Liquid; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Levodopa; Male; Peroxides; Rats; Rats, Inbred Strains; Reserpine; Synaptosomes; tert-Butylhydroperoxide | 1988 |
Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Brain; Brocresine; Chromatography, High Pressure Liquid; Deferoxamine; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; Functional Laterality; Homovanillic Acid; Iron; Iron Chelating Agents; Levodopa; Male; Motor Activity; Neurodegenerative Diseases; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |